The Early Days
groupH was set-up in April 2005 by Erik Holzinger, leaving his role as Principal at professional advisory firm Wood Mackenzie’s London City office. The early days focused on building a virtual network of professionals with the experience and skills to successfully engage in and complete opportunity assessments for novel Rx treatments developed by the Pharmaceutical and Medical Device industry. Erik felt it was time that the professional services industry, and the consulting industry in particular, change the way it viewed itself and how it collaborated with biotech, speciality Pharma and Big-Pharma clients but also how the team members worked with each other. The virtual model was relatively new at the time but proved the perfect vehicle to bring the right expertise to each engagement. Importantly, nurturing a culture of shared values made this model work and attracted both, new associates and more senior members to the core team.
Iain Clark, a former colleague from Wood Mackenzie, joined groupH as co-director in 2008. He was followed by Simon Smyth who also joined as a senior member of the core team, strengthening groupH’s capabilities and capacity to conduct large global projects with significant amount of insightful primary and secondary research. Also from Wood Mackenzie, Morris Paterson joined the core team in 2010 and then Sara Uttley from AstraZeneca in 2013. Nicolas Touchot was welcomed in 2013 reflecting the importance of market access and payer consultations as part of early clinical development decision making and adding leading market access methodologies and cutting edge insight to the team.
In 2016, groupH set up groupH Inc. in San Francisco to further grow our North American operations. In 2018, we welcomed Zach Donnell PhD to the San Francisco office in his role as core team member and expert in market opportunity assessments and disease area strategy across a wide range of therapeutic areas.
Today, groupH continues to pursue growth and developing its network of experts through successfully collaborating with individuals or to enter key-strategic partnership such as with e.g. Boston-based Chris Serjak from ALIGN2ACTION and California based-Reid Bengard from Aquest Research.